Avastin® (bevacizumab), in combination with carboplatin and paclitaxel, is approved to treat advanced nonsquamous non–small cell lung cancer (nsNSCLC) in people who have not yet received chemotherapy for their advanced disease.

In a clinical study, Avastin was shown to extend the life of people with advanced nsNSCLC when taken with carboplatin and paclitaxel (chemotherapy) instead of chemotherapy alone (12.3 months vs. 10.3 months).

In a clinical study, it was shown that adding Avastin to carboplatin and paclitaxel (chemotherapy) can help people with advanced nsNSCLC:

Advanced non small cell lung cancer benefits

Individual results may vary.

What are the side effects of Avastin in advanced nsNSCLC?

See the table below for select side effects that increased by 2% or more in patients who added Avastin to carboplatin and paclitaxel (chemotherapy).

Life-threatening to fatal side effects

Talk to your doctor about the benefits and risks of Avastin. To learn about the possible side effects of taking Avastin, visit the Side Effects page.

Financial resources calculator

GET FINANCIAL SUPPORT

Questions about Avastin treatment costs? Let us help you understand your financial assistance options.

How Avastin is designed to work

FIND OUT HOW AVASTIN IS DESIGNED TO WORK

Avastin is a tumor starving therapy. Read more about how it’s designed to work.

Avastin® (bevacizumab) Patient Resources

PATIENT RESOURCES

Find helpful information and support.